Pharmidex is an AAALAC-accredited, UK-based CRO founded in 2002. 
We provide high-quality, cost-effective, flexible and rapid solutions in drug metabolism and pharmacokinetics (DMPK), bioanalysis (non-GLP/GLP/GCP), toxicology (non-GLP/GLP), histology, clinical chemistry, hematology, and in vitro ADME. 

Pharmidex also offers in silico modelling and efficacy models supporting oncology, CNS, respiratory, stroke, autoimmune, and metabolic disease programs.

We work with over 250 global clients, including medical charities, academic groups, biotech, and pharma, and have undertaken over 15,000 studies. In addition to our fee-for-service offering, Pharmidex actively seeks collaboration opportunities in grant-funded projects. To date, we have successfully participated in over 30 collaborative grant-funded projects, partnering with more than 167 global collaborators.

Biotechnology

Clinical Trials

Health Care

Life Sciences

Pharmaceutical

Pharmidex

Mo Alavijeh

Ian Knowles

Martin Barrett

Radhakrishnan Venkatasamy

Jewel Ahmed

Rob Jenkins

Dr. Saurabh Jain

Saravanan Masilamani

John Bakker

Ash Alavijeh

Pharmidex

Org chart

Teams

Offices